• Describing our expertise in metagenomics discovery and protein engineering with the help of High Throughput Evolution Platform for Discovery and Optimization of Novel Editors (HEPDONE) system.
• Introduce our proprietary lipid nanoparticle (LNP) mediated delivery systems targeting both liver and HSCs in the bone marrow
• Recent clinical trial readouts from our multiple ongoing in vivo genome editing programs in China will be discussed

NEW DATA

NEW COMPANY